Kotai Bio
Minoh, JP · 1 known investors
KOTAI Biotechnologies develops an immune AI platform and big data analysis pipeline that combines artificial intelligence with immunology for antibody and immune-repertoire analysis. The company serves pharmaceutical and life-science research applications such as antibody modeling, single-cell analysis, and cancer and infectious-disease immunology research.
Founders & leadership
山和
山下 和男共同創業者・代表取締役 (Co-founder & CEO)
KY
Kazuo YamashitaCo-founder & CEO
Investors · 1
Frequently asked questions
- What does Kotai Bio do?
- KOTAI Biotechnologies develops an immune AI platform and big data analysis pipeline that combines artificial intelligence with immunology for antibody and immune-repertoire analysis. The company serves pharmaceutical and life-science research applications such as antibody modeling, single-cell analysis, and cancer and infectious-disease immunology research.
- Who founded Kotai Bio?
- Kotai Bio was founded by 山下 和男, Kazuo Yamashita.
- Who are Kotai Bio's investors?
- Kotai Bio's investors include OSAKA University Venture Capital.
- Where is Kotai Bio headquartered?
- Kotai Bio is headquartered in Minoh, JP.